Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Syndax Pharmaceuticals
SNDX
Other General and Administrative Expense
Other General and Administrative Expense at other companies
Cousins Properties
CUZ
$11.84M
+10.6%
APA
Artisan Partners Asset Management Inc.
APAM
$11.42M
+30.3%
Kayne Anderson BDC
KBDC
$575K
-1.0%
Sixth Street Specialty Lending
TSLX
$1.37M
+2.4%
KEE
Keel Infrastructure Corp. Common Stock
KEEL
$183.75K
—
World Acceptance
WRLD
$11.1M
+9.5%
Segments
By segment
See full
Biopharmaceutical Cancer Therapeutics
$5.14M
+16.5%
Other financials
Income statement
See full
Revenue
$64.9M
+224%
Operating income
-$34.2M
+59.2%
Net income
-$42.7M
+49.7%
EPS (diluted)
-$0.48
+51.0%
Balance sheet
See full
Cash & equivalents
$130.9M
-15.0%
Total debt
$350.5M
+4.2%
Total equity
$41.6M
-80.6%
Total assets
$472.7M
-26.2%
Cash flow
See full
Operating cash flow
-$50.3M
+47.1%
CapEx
$46.8K
—
Free cash flow
-$80.8M
-17.6%
Valuation
See full
Market cap
$1.77B
+95.0%
Enterprise value
$1.99B
+84.0%
P/S
8.1×
-12.6×
Profitability
See full
Operating margin
-102.8%
-47.8pp
Net margin
-111.9%
-51.5pp
FCF margin
-187.2%
-85.4pp
Returns & leverage
See full
Return on equity
-189.5%
-8,509pp
Debt / equity
8.4×
+6.9×
Current ratio
5.5×
-0.3×